CLINICAL_TRIALS
trial_result
· 2017-03-31
Clinical Trial Update: Propranolol for Diabetic Retinopathy [Phase 1]
Summary
A Phase 1 trial evaluating propranolol for proliferative diabetic retinopathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Proliferative Diabetic Retinopathy | Phase 1 | Status: COMPLETED